October 8th, 2024
🎉A 20 M€ #milestone ! 🎉
Fabentech continues its trajectory and completes the first steps of its #equitystory !
A French #biopharmaceutical company specializing in the development and production of therapeutic products against biological threats, Fabentech has just announced support of up to €20M from the European Investment Bank (EIB) through #HERAInvest program.
Beyond strengthening #R&D capacities, this allows to increase industrial efforts and international impact. A key step forward in global preparedness against biological and bioterrorist threats.
Happy to have finalized this transaction with Jeremy Ballet.
đź‘Ź We take on challenges together, and celebrate victories together. Congratulations to SĂ©bastien IVA and the entire team for this major milestone.Â
 #Investment #EIBFinancing #FabShield®
February 5th, 2024
For almost 4 years now, the relationship driven by Bpifrance Le Hub betweenFab’entech and LallianSe – Life Sciences Integrator has been enriched and developed.
Initiated as #SparringPartner following the arrival of SĂ©bastien IVA as Chairman of the Management Board in 2020, the translation of the vision, the outline of the roadmap and the articulation of the investment thesis have gradually strengthened the agenda of interactions and existing support.
A real pleasure to support the evolution of #Fabentech towards its position as European leader!
Discover all of our feedback here 👉 link to the interview